APA (7th ed.) Citation

Xu, H., Cao, D., Zhou, D., Zhao, N., Tang, X., Shelat, V. G., . . . Ge, W. (2023). Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: A systematic review and meta-analysis. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-11488-9

Chicago Style (17th ed.) Citation

Xu, Huilin, et al. "Baseline Albumin-Bilirubin Grade as a Predictor of Response and Outcome of Regorafenib Therapy in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-analysis." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-11488-9.

MLA (9th ed.) Citation

Xu, Huilin, et al. "Baseline Albumin-Bilirubin Grade as a Predictor of Response and Outcome of Regorafenib Therapy in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-analysis." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-11488-9.